DOWNSTREAM PROCESSING MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Downstream Processing Market, By Technique (Purification Techniques, Solid-Liquid Separation, and Clarification/Concentration), By Product (Chromatography Columns and Resins, Filters, Evaporators, Centrifuges, and Other Products), By Application (Antibodies Production, Vaccines Production, Insulin Production, and Other Applications), By End User (Biopharmaceutical Companies, CMOs/CDMOs, Research Institutes, CROs, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

In June 2022, Merck, a multinational pharmaceutical company, partnered with Agilent Technologies, a life sciences company, to bridge the industry gap in process analytical technologies (PAT) for downstream processing. Through this collaboration, Merck's bioprocess portfolio is combined with Agilent Technologies' advanced analytical products to enhance real-time monitoring and automated process control of critical process parameters (CPPs) and critical quality attributes (CQAs) in downstream processing (DSP).
In February 2022, Sartorius Stedim Biotech, a biopharmaceutical industry, completed the acquisition of the chromatography division of Novasep. This division encompasses chromatography systems primarily designed for smaller biomolecules such as oligonucleotides, peptides, and insulin, as well as innovative systems for the continuous manufacturing of biologics.
In April 2022, Thermo Fisher Scientific, a biotechnology company, inaugurated a bioprocessing manufacturing facility in Ogden, Utah, dedicated to the advancement of biologics and vaccines.
In June 2022, Bio-Rad Laboratories, Inc., a U.S.-based developer and manufacturer of specialized technological products for the life science, launched the CHT prepacked Foresight Pro Columns to cater to downstream process-scale chromatography needs across all phases of biological drug research and production.